Homozygous familial hypercholesterolemia: Summarized case reports
- 1 February 2017
- journal article
- case report
- Published by Elsevier BV in Atherosclerosis
- Vol. 257, 86-89
- https://doi.org/10.1016/j.atherosclerosis.2017.01.002
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Improved cardiovascular outcomes following temporal advances in lipid-lowering therapy in a genetically-characterised cohort of familial hypercholesterolaemia homozygotesAtherosclerosis, 2015
- Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trialThe Lancet, 2014
- Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype–phenotype relationship, and clinical outcomeEuropean Heart Journal, 2014
- Pharmacogenetic aspects in familial hypercholesterolemia with the special focus on FHMarburg (FH p.W556R)Clinical Research in Cardiology Supplements, 2012
- Sudden Death in a 4-Year-Old Boy: A Near-Complete Occlusion of the Coronary Artery Caused by an Aggressive Low-Density Lipoprotein Receptor Mutation (W556R) in Homozygous Familial HypercholesterolemiaThe Journal of Pediatrics, 2011
- Mutations in PCSK9 cause autosomal dominant hypercholesterolemiaNature Genetics, 2003
- Improved survival of patients with homozygous familial hypercholesterolaemia treated with plasma exchange.BMJ, 1985
- Cardiovascular features of homozygous familial hypercholesterolemia: Analysis of 16 patientsThe American Journal of Cardiology, 1984
- Successful plasmapheresis in a 4-year-old child with homozygous familial hypercholesterolemiaThe Journal of Pediatrics, 1980
- Experiences with the Homozygous Cases of Familial HypercholesterolemiaAnnals of Nutrition and Metabolism, 1973